Peanut allergy treatment progress.

Peanut allergy treatment progress. “The median tolerated dose increased from 30 mg (equivalent to approximately 1/8th of a peanut) to 3000 mg (12 peanuts) at the exit challenge, representing a 100-fold increase.” This phase II trial shows promising results for peanut oral immunotherapy in adults, achieving desensitization and improving quality of life in the participants. ~ learn more